ProPhase Labs, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $) In Thousands, except Share data	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings (Deficit) [Member]	Treasury Stock [Member]
Balance at Dec. 31, 2011	$ 11,226us-gaap_StockholdersEquity	$ 10	$ 41,552	$ (4,699)	$ (25,637)
Balance (in shares) at Dec. 31, 2011		14,825,583
Net income (loss)	(1,091)us-gaap_NetIncomeLoss			(1,091)
Proceeds from exercise of stock options (in shares)	0
Share-based compensation expense	153		153
Common stock granted pursuant to a compensation plan	93		93
Common stock granted pursuant to a compensation plan (in shares)		10,757
Common stock issued (Note 5)	1,070	1	1,069
Common stock issued (Note 5) (in shares)		883,722
Balance at Dec. 31, 2012	11,451us-gaap_StockholdersEquity	11	42,867	(5,790)	(25,637)
Balance (in shares) at Dec. 31, 2012		15,720,062
Net income (loss)	405us-gaap_NetIncomeLoss			405
Proceeds from exercise of stock options	27		27
Proceeds from exercise of stock options (in shares)	25,000	25,000
Share-based compensation expense	160		160
Common stock granted pursuant to a compensation plan	109		109
Common stock granted pursuant to a compensation plan (in shares)		66,470
Common stock issued (Note 5)	444		444
Common stock issued (Note 5) (in shares)		289,474
Balance at Dec. 31, 2013	12,596us-gaap_StockholdersEquity	11	43,607	(5,385)	(25,637)
Balance (in shares) at Dec. 31, 2013		16,101,006
Net income (loss)	(7,834)us-gaap_NetIncomeLoss			(7,834)
Proceeds from exercise of stock options (in shares)	0
Share-based compensation expense	472		472
Common stock granted pursuant to a compensation plan	179		179
Common stock granted pursuant to a compensation plan (in shares)		128,327
Common stock issued for services performed (Note 5)	393		393
Common stock issued for services performed (Note 5) (in shares)		300,000
Common stock issued (Note 5)	4,910	2	4,908
Common stock issued (Note 5) (in shares)		3,259,727
Treasury stock acquired puruant to a settlement agreement (Note 5)	0		5,105		(5,105)
Treasury stock acquired puruant to a settlement agreement (Note 5) (in shares)		(3,896,764)
Balance at Dec. 31, 2014	$ 10,716us-gaap_StockholdersEquity	$ 13	$ 54,664	$ (13,219)	$ (30,742)
Balance (in shares) at Dec. 31, 2014		15,892,296